Using social listening data to monitor misuse and nonmedical use of bupropion: A content analysis

JMIR Public Health and Surveillance

Volumn 3, Issue 1, 2017, Pages

  Anderson, Laurie S ^a   Bell, Heidi G ^b   Gilbert, Michael ^c   Davidson, Julie E ^d   Winter, Christina ^d   Barratt, Monica J ^e,f,g   Win, Beta ^d   Painter, Jeffery L ^a   Menone, Christopher ^c   Sayegh, Jonathan ^g   Dasgupta, Nabarun ^c  

^a GLAXOSMITHKLINE   (United States)

^b Gyra MediPharm Consulting   (United States)

^c Epidemico Inc   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Bluelightorg   (United States)

^g Kadiant Analytics   (United States)

Author keywords

Amitriptyline; Bupropion; Community based participatory research; Harm reduction; Internet; Pharmacovigilance; Prescription drug misuse; Social media; Substance related disorders; Venlafaxine hydrochloride

Indexed keywords

EID: 85030536579     PISSN: None     EISSN: 23692960     Source Type: Journal    
DOI: 10.2196/publichealth.6174     Document Type: Article

References (95)

1. Whitehouse. 2011. Epidemic: Responding to America's Prescription Drug Abuse Crisis URL:https://www.whitehouse.gov/ sites/default/files/ondcp/issues-content/prescription-drugs/rx_abuse_plan.pdf [accessed 2017-01-16] [WebCite Cache ID 6nYyzSftn]
2. SAMHSA. 2015. Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No SMA 15-4927, NSDUH Series H-50) URL:https://www.samhsa.gov/data/sites/default/files/ NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf [accessed 2017-01-16] [WebCite Cache ID 6nZ0WkjVC]
3. Evans EA, Sullivan MA. Abuse and misuse of antidepressants. Subst Abuse Rehabil 2014;5:107-120 [FREE Full text] [doi: 10.2147/SAR.S37917] [Medline: 25187753]
4. Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 1989 Oct;251(1):150-155. [Medline: 2529365]
5. de la Garza R, Johanson CE. Discriminative stimulus properties of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys. J Pharmacol Exp Ther 1987 Dec;243(3):955-962. [Medline: 2891839]
6. Kamien JB, Woolverton WL. A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. J Pharmacol Exp Ther 1989 Mar;248(3):938-946. [Medline: 2649658]
7. Lamb RJ, Griffiths RR. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology (Berl) 1990;102(2):183-190. [Medline: 2125734]
8. Griffith JD, Carranza J, Griffith C, Miller LL. Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry 1983 May;44(5 Pt 2):206-208. [Medline: 6406459]
9. Miller L, Griffith J. A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers. Psychopharmacology (Berl) 1983;80(3):199-205. [Medline: 6412263]
10. Rush CR, Kollins SH, Pazzaglia PJ. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol 1998 Feb;6(1):32-44. [Medline: 9526144]
11. Zernig G, De Wit H, Telser S, Nienhusmeier M, Wakonigg G, Sturm K, et al. Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting. Pharmacology 2004 Apr;70(4):206-215. [doi: 10.1159/000075550] [Medline: 15001822]
12. Steele LS, Macdonald EM, Gomes T, Hollands S, Paterson JM, Mamdani MM, Canadian Drug SafetyEffectiveness Research Network. Rates of anomalous bupropion prescriptions in Ontario, Canada. Ann Fam Med 2015;13(4):343-346 [FREE Full text] [doi: 10.1370/afm.1818] [Medline: 26195679]
13. McCormick J. Recreational bupropion abuse in a teenager. Br J Clin Pharmacol 2002 Feb;53(2):214 [FREE Full text] [Medline: 11851650]
14. Baribeau D, Araki KF. Intravenous bupropion: a previously undocumented method of abuse of a commonly prescribed antidepressant agent. J Addict Med 2013;7(3):216-217. [doi: 10.1097/ADM.0b013e3182824863] [Medline: 23519045]
15. Khurshid KA, Decker DH. Bupropion insufflation in a teenager. J Child Adolesc Psychopharmacol 2004;14(1):157-158. [doi: 10.1089/104454604773840634] [Medline: 15142406]
16. Welsh CJ, Doyon S. Seizure induced by insufflation of bupropion. N Engl J Med 2002 Sep 19;347(12):951. [doi: 10.1056/NEJM200209193471222] [Medline: 12239274]
17. Langguth B, Hajak G, Landgrebe M, Unglaub W. Abuse potential of bupropion nasal insufflation: a case report. J Clin Psychopharmacol 2009 Dec;29(6):618-619. [doi: 10.1097/JCP.0b013e3181c09475] [Medline: 19910738]
18. Hill S, Sikand H, Lee J. A case report of seizure induced by bupropion nasal insufflation. Prim Care Companion J Clin Psychiatry 2007;9(1):67-69 [FREE Full text] [Medline: 17599174]
19. Del Paggio D. Psychotropic medication abuse in correctional facilities. Mental Health Clinician 2012;1(8):187-188. [doi: 10.9740/mhc.n95631]
20. Kim D, Steinhart B. Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. Can J Emerg Med 2010 Mar;12(2):158-161. [Medline: 20219165]
21. Phillips D. Wellbutrin: misuse and abuse by incarcerated individuals. J Addict Nurs 2012 Feb;23(1):65-69. [doi: 10.3109/10884602.2011.647838] [Medline: 22468662]
22. Yoon G, Westermeyer J. Intranasal bupropion abuse: case report. Am J Addict 2013;22(2):180. [doi: 10.1111/j.1521-0391.2013.00329.x] [Medline: 23414507]
23. Hilliard WT, Barloon L, Farley P, Penn JV, Koranek A. Bupropion diversion and misuse in the correctional facility. J Correct Health Care 2013 Jul;19(3):211-217. [doi: 10.1177/1078345813486448] [Medline: 23788587]
24. Reeves RR, Ladner ME. Additional evidence of the abuse potential of bupropion. J Clin Psychopharmacol 2013 Aug;33(4):584-585. [doi: 10.1097/JCP.0b013e318295fe2f] [Medline: 23771197]
25. GSKsource. Research Triangle Park, NC: GlaxoSmithKline; 2016. Wellbutrin SR (bupropion hydrochloride) Sustained-Release Tablets URL:https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/ Prescribing_Information/Wellbutrin_SR/pdf/WELLBUTRIN-SR-PI-MG.PDF [accessed 2017-01-16] [WebCite Cache ID 6nZ0AYqaG]
26. Bibeau KB, Henegar C. GSK-clinicalstudyregister. Assessment of bupropion misuse and abuse 2004-2011 URL:http:/ /www.gsk-clinicalstudyregister.com/search/?study_ids=201235 [accessed 2016-10-21] [WebCite Cache ID 6lQVXpRL2]
27. Dasgupta N, Schnoll SH. Signal detection in post-marketing surveillance for controlled substances. Drug Alcohol Depend 2009 Dec 1;105(Suppl 1):S33-S41. [doi: 10.1016/j.drugalcdep.2009.05.019] [Medline: 19616902]
28. Pew Research Center. Health Fact Sheet: Highlights of the Pew Internet Project's research related to health and health care URL:http://www.pewinternet.org/fact-sheets/health-fact-sheet [accessed 2016-10-21] [WebCite Cache ID 6lQVguHmQ]
29. Bell HG, Schifano L, Rodriguez HW, Pierce CE, Dasgupta N, Shaikh S, et al. Pharmaceutical Products and Vaccines Discussed in Social Media: Which Ones are Patients Talking About. 2015 Presented at: ISPOR 18th Annual European Congress; November 7-11, 2015; Milan, Italy. [doi: 10.1016/j.jval.2015.09.2570]
30. Coppola M, Mondola R. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 2012 Jan 5;208(1):12-15. [doi: 10.1016/j.toxlet.2011.10.002] [Medline: 22008731]
31. Ware MA, St Arnaud-Trempe E. The abuse potential of the synthetic cannabinoid nabilone. Addiction 2010 Mar;105(3):494-503. [doi: 10.1111/j.1360-0443.2009.02776.x] [Medline: 20402993]
32. Johnstone AC, Lea RA, Brennan KA, Schenk S, Kennedy MA, Fitzmaurice PS. Benzylpiperazine: a drug of abuse. J Psychopharmacol 2007 Nov;21(8):888-894. [doi: 10.1177/0269881107077260] [Medline: 17606471]
33. Butler SF, Fernandez KC, Chang A, Benoit C, Morey LC, Black R, et al. Measuring attractiveness for abuse of prescription opioids. Pain Med 2010 Jan;11(1):67-80 [FREE Full text] [doi: 10.1111/j.1526-4637.2009.00736.x] [Medline: 20002325]
34. Chiauzzi E, Dasmahapatra P, Lobo K, Barratt MJ. Participatory research with an online drug forum: a survey of user characteristics, information sharing, and harm reduction views. Subst Use Misuse 2013 Jun;48(8):661-670. [doi: 10.3109/10826084.2013.800117] [Medline: 23750771]
35. Baggott MJ, Erowid E, Erowid F, Galloway GP, Mendelson J. Use patterns and self-reported effects of Salvia divinorum: an internet-based survey. Drug Alcohol Depend 2010 Oct 1;111(3):250-256. [doi: 10.1016/j.drugalcdep.2010.05.003] [Medline: 20627425]
36. Daniulaityte R, Carlson R, Falck R, Cameron D, Perera S, Chen L, et al. “I just wanted to tell you that loperamide WILL WORK”: a web-based study of extra-medical use of loperamide. Drug Alcohol Depend 2013 Jun 1;130(1-3):241-244 [FREE Full text] [doi: 10.1016/j.drugalcdep.2012.11.003] [Medline: 23201175]
37. Daniulaityte R, Nahhas RW, Wijeratne S, Carlson RG, Lamy FR, Martins SS, et al. “Time for dabs”: Analyzing Twitter data on marijuana concentrates across the U.S. Drug Alcohol Depend 2015 Oct 1;155:307-311. [doi: 10.1016/j.drugalcdep.2015.07.1199] [Medline: 26338481]
38. Powell GE, Seifert HA, Reblin T, Burstein PJ, Blowers J, Menius JA, et al. Social media listening for routine post-marketing safety surveillance. Drug Saf 2016 May;39(5):443-454. [doi: 10.1007/s40264-015-0385-6] [Medline: 26798054]
39. Sarker A, Ginn R, Nikfarjam A, O'Connor K, Smith K, Jayaraman S, et al. Utilizing social media data for pharmacovigilance: a review. J Biomed Inform 2015 Apr;54:202-212 [FREE Full text] [doi: 10.1016/j.jbi.2015.02.004] [Medline: 25720841]
40. Yang CC, Yang H, Jiang L. Post marketing drug safety surveillance using publicly available health-consumer-contributed content in social media. ACM Trans Manage Inf Syst 2014 Apr 01;5(1):1-21. [doi: 10.1145/2576233]
41. Yang M, Kiang M, Shang W. Filtering big data from social media-building an early warning system for adverse drug reactions. J Biomed Inform 2015 Apr;54:230-240 [FREE Full text] [doi: 10.1016/j.jbi.2015.01.011] [Medline: 25688695]
42. Chary M, Genes N, McKenzie A, Manini AF. Leveraging social networks for toxicovigilance. J Med Toxicol 2013 Jun;9(2):184-191 [FREE Full text] [doi: 10.1007/s13181-013-0299-6] [Medline: 23619711]
43. Cameron D, Smith GA, Daniulaityte R, Sheth AP, Dave D, Chen L, et al. PREDOSE: a semantic web platform for drug abuse epidemiology using social media. J Biomed Inform 2013 Dec;46(6):985-997 [FREE Full text] [doi: 10.1016/j.jbi.2013.07.007] [Medline: 23892295]
44. Sarker A, O'Connor K, Ginn R, Scotch M, Smith K, Malone D, et al. Social media mining for toxicovigilance: automatic monitoring of prescription medication abuse from Twitter. Drug Saf 2016 Mar;39(3):231-240 [FREE Full text] [doi: 10.1007/s40264-015-0379-4] [Medline: 26748505]
45. Hanson CL, Cannon B, Burton S, Giraud-Carrier C. An exploration of social circles and prescription drug abuse through Twitter. J Med Internet Res 2013;15(9):e189 [FREE Full text] [doi: 10.2196/jmir.2741] [Medline: 24014109]
46. McNaughton EC, Coplan PM, Black RA, Weber SE, Chilcoat HD, Butler SF. Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse. J Med Internet Res 2014;16(5):e119 [FREE Full text] [doi: 10.2196/jmir.3397] [Medline: 24800858]
47. McNaughton EC, Black RA, Weber SE, Butler SF. Assessing abuse potential of new analgesic medications following market release: an evaluation of Internet discussion of tapentadol abuse. Pain Med 2015 Jan;16(1):131-140 [FREE Full text] [doi: 10.1111/pme.12547] [Medline: 25244069]
48. Shutler L, Nelson LS, Portelli I, Blachford C, Perrone J. Drug use in the Twittersphere: a qualitative contextual analysis of Tweets about prescription drugs. J Addict Dis 2015;34(4):303-310. [doi: 10.1080/10550887.2015.1074505] [Medline: 26364675]
49. Shutler L, Nelson LS, Portelli I, Blachford C, Perrone J. Prescription opioids in the Twittersphere: a contextual analysis of tweets about prescription drugs. Ann Emerg Med 2013;62(4S):S22. [doi: 10.1016/j.annemergmed.2013.07.169]
50. Omidian A, Mastropietro DJ, Omidian H. Reported methods of abuse for common prescription analgesic opioids. J Dev Drugs 2013;03(02):1-3. [doi: 10.4172/2329-6631.1000120]
51. Barratt MJ, Lenton S, Allen M. Internet content regulation, public drug websites and the growth in hidden Internet services. Drugs: Education, Prevention and Policy 2012 Dec 12;20(3):195-202. [doi: 10.3109/09687637.2012.745828]
52. Barratt MJ. Discussing illicit drugs in public internet forums: visibility, stigma, pseudonymity. 2011 Presented at: Fifth International Conference on Communities and Technologies; June 29-July 2, 2011; Brisbane, Australia p. 159-168.
53. Raynes-Goldie K. Aliases, creeping, and wall cleaning: understanding privacy in the age of Facebook. First Monday 2010;15(1) [FREE Full text]
54. Eysenbach G. Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet. J Med Internet Res 2009;11(1):e11 [FREE Full text] [doi: 10.2196/jmir.1157] [Medline: 19329408]
55. Cole-Lewis H, Pugatch J, Sanders A, Varghese A, Posada S, Yun C, et al. Social Listening: a content analysis of e-cigarette discussion on Twitter. J Med Internet Res 2015;17(10):e243 [FREE Full text] [doi: 10.2196/jmir.4969] [Medline: 26508089]
56. GSKsource. Research Triangle Park, NC: GlaxoSmithKline; 2015. Zyban (buproion hydrochloride) Sustained-Release Tablets URL:https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Zyban/ pdf/ZYBAN-PI-MG.PDF [accessed 2017-01-16] [WebCite Cache ID 6nZ240NMr]
57. Vento AE, Schifano F, Gentili F, Pompei F, Corkery JM, Kotzalidis GD, et al. Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse. Ann Ist Super Sanita 2013;49(4):402-405 [FREE Full text] [Medline: 24334787]
58. AApharma. Vaughan, ON: AA Pharma, Inc; 2010. Elavil Monograph URL:https://www.aapharma.ca/downloads/en/PIL/ ELAVIL_PM.pdf [accessed 2017-01-16] [WebCite Cache ID 6nZ2BW2xJ]
59. Delisle JD. A case of amitriptyline abuse. Am J Psychiatry 1990 Oct;147(10):1377-1378. [Medline: 2400006]
60. Wohlreich MM, Welch W. Amitriptyline abuse presenting as acute toxicity. Psychosomatics 1993;34(2):191-193. [doi: 10.1016/S0033-3182(93)71918-0] [Medline: 8456167]
61. Hepburn S, Harden J, Grieve JHK, Hiscox J. Deliberate misuse of tricyclic antidepressants by intravenous drug users-case studies and report. Scott Med J 2005 Aug;50(3):131-133. [Medline: 16164005]
62. Prahlow JA, Landrum JE. Amitriptyline abuse and misuse. Am J Forensic Med Pathol 2005 Mar;26(1):86-88. [Medline: 15725783]
63. Peles E, Schreiber S, Adelson M. Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT). Eur Neuropsychopharmacol 2008 Mar;18(3):188-193. [doi: 10.1016/j.euroneuro.2007.10.001] [Medline: 17997285]
64. Shenouda R, Desan PH. Abuse of tricyclic antidepressant drugs: a case series. J Clin Psychopharmacol 2013 Jun;33(3):440-442. [doi: 10.1097/JCP.0b013e3182901142] [Medline: 23609400]
65. Labeling.pfizer. Philadelphia, PA: Pfizer; 2016. Effexor XR (venlafaxine hydrochloride) Extended-Release capsule URL:http://labeling.pfizer.com/showlabeling.aspx?ID=100 [accessed 2016-10-21] [WebCite Cache ID 6lQVtBV90]
66. Quaglio G, Schifano F, Lugoboni F. Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse. Addiction 2008 Sep;103(9):1572-1574. [doi: 10.1111/j.1360-0443.2008.02266.x] [Medline: 18636997]
67. Sattar SP, Grant KM, Bhatia SC. A case of venlafaxine abuse. N Engl J Med 2003 Feb 20;348(8):764-765. [doi: 10.1056/NEJM200302203480822] [Medline: 12594330]
68. Neuendorf K. The content analysis guidebook. Thousand Oaks, CA: Sage Publications; 2002.
69. Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, et al. Digital drug safety surveillance: monitoring pharmaceutical products in twitter. Drug Saf 2014 May;37(5):343-350 [FREE Full text] [doi: 10.1007/s40264-014-0155-x] [Medline: 24777653]
70. MedDRA. 2016. MedDRA Medical Dictionary for Regulatory Activities URL:http://www.meddra.org/how-to-use/ support-documentation/English [accessed 2017-01-16] [WebCite Cache ID 6nZ2S0DQx]
71. Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, Analgesic, Anesthetic, and Addiction Clinical Trials, Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain 2013 Nov;154(11):2287-2296. [doi: 10.1016/j.pain.2013.05.053] [Medline: 23792283]
72. WHO. Geneva: World Health Organization; 1994. Lexicon of alcohol and drug terms URL:http://www.who.int/ substance_abuse/terminology/who_lexicon/en/print.html [accessed 2016-10-21] [WebCite Cache ID 6lQW6QwZ4]
73. FDA. Silver Spring, MD: US Food and Drug Administration Center for Drug Evaluation and Research; 2010. Guidance for industry: assessment of abuse potential of drugs URL:http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM198650.pdf [accessed 2017-01-16] [WebCite Cache ID 6nZ2XljEW]
74. FDA. Silver Spring, MD: US Food and Drug Administration Center for Drug Evaluation and Research; 2010. Joint meeting of the anesthetic and life support drugs advisory committee and the drug safety and risk management advisory committee URL:http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM217510.pdf [accessed 2017-01-16] [WebCite Cache ID 6nZ3AnUET]
75. Larance B, Degenhardt L, Lintzeris N, Winstock A, Mattick R. Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Rev 2011 May;30(3):236-245. [doi: 10.1111/j.1465-3362.2010.00283.x] [Medline: 21545553]
76. Casperson TA, Painter JL, Dietrich J. Strategies for distributed curation of social media data for safety and pharmacovigilance. 2016 Presented at: The Steering Committee of The World Congress in Computer Science, Computer Engineering and Applied Computing (WorldComp); 2016; Las Vegas, NV URL:http://www.javastats.com/publications/gsk_worldcomp_2016. pdf
77. Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc 2011;18(4):441-448 [FREE Full text] [doi: 10.1136/amiajnl-2011-000116] [Medline: 21515544]
78. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 Mar;33(1):159-174. [Medline: 843571]
79. McKee H, Porter JE. Writing.ucsb. 2008. The ethics of digital writing research: a rhetorical approach URL:http://www. writing.ucsb.edu/wrconf08/Pdf_Articles/McKee_Article.pdf [accessed 2016-05-19] [WebCite Cache ID 6hdCfHV9t]
80. Daniulaityte R, Carlson R, Brigham G, Cameron D, Sheth A. “Sub is a weird drug:” a web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms. Am J Addict 2015 Aug;24(5):403-409. [doi: 10.1111/ajad.12213] [Medline: 26009867]
81. Butler SF, Venuti SW, Benoit C, Beaulaurier RL, Houle B, Katz N. Internet surveillance: content analysis and monitoring of product-specific internet prescription opioid abuse-related postings. Clin J Pain 2007 Sep;23(7):619-628. [doi: 10.1097/AJP.0b013e318125c5cf] [Medline: 17710013]
82. Barratt MJ, Lenton S. Beyond recruitment? Participatory online research with people who use drugs. International Journal of Internet Research Ethics 2010;3:69-86 [FREE Full text]
83. Apps.WHO. Geneva: World Health Organization; 1984. Guidelines for the control of narcotic and pychotropic substances URL:http://apps.who.int/iris/bitstream/10665/39299/1/9241541725_eng.pdf [accessed 2017-01-16] [WebCite Cache ID 6htr2F0o7]
84. World Health Organization. WHO Expert Committee on Drug Dependence. Thirty-sixth report. World Health Organ Tech Rep Ser 2015(991):1-50. [Medline: 26062388]
85. Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Muñoz A. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med 2007 Mar;8(2):157-170 [FREE Full text] [doi: 10.1111/j.1526-4637.2006.00259.x] [Medline: 17305687]
86. Butler SF, Budman SH, Licari A, Cassidy TA, Lioy K, Dickinson J, et al. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse. Pharmacoepidemiol Drug Saf 2008 Dec;17(12):1142-1154. [doi: 10.1002/pds.1659] [Medline: 18932173]
87. Novak SP, Peiper NC, Zarkin GA. Nonmedical prescription pain reliever and alcohol consumption among cannabis users. Drug Alcohol Depend 2016 Feb 1;159:101-108. [doi: 10.1016/j.drugalcdep.2015.11.039] [Medline: 26748409]
88. Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, et al. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN). Clin Toxicol (Phila) 2015 Nov;53(9):893-900. [doi: 10.3109/15563650.2015.1088157] [Medline: 26503789]
89. Mounteney J, Griffiths P, Sedefov R, Noor A, Vicente J, Simon R. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction 2016 Jan;111(1):34-48. [doi: 10.1111/add.13056] [Medline: 26419329]
90. Burns L, Roxburgh A, Bruno R, Van Buskirk J. Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia. Drug Test Anal 2014;6(7-8):840-845. [doi: 10.1002/dta.1613] [Medline: 24574080]
91. van Mierlo T. The 1% rule in four digital health social networks: an observational study. J Med Internet Res 2014;16(2):e33 [FREE Full text] [doi: 10.2196/jmir.2966] [Medline: 24496109]
92. Alexa. 2016. Competitive Intelligence. Site Info URL:http://www.alexa.com/siteinfo/bluelight.org [accessed 2017-01-16] [WebCite Cache ID 6lQWDXGcF]
93. Van Hout MC, Hearne E. “Word of mouse”: indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine. J Psychoactive Drugs 2015;47(1):30-41. [doi: 10.1080/02791072.2014.974002] [Medline: 25715070]
94. Schifano F, D'Offizi S, Piccione M, Corazza O, Deluca P, Davey Z, et al. Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother Psychosom 2011;80(2):118-122. [doi: 10.1159/000321079] [Medline: 21212719]
95. Van Hout MC. Nod and wave: an Internet study of the codeine intoxication phenomenon. Int J Drug Policy 2015 Jan;26(1):67-77. [doi: 10.1016/j.drugpo.2014.06.016] [Medline: 25052240]